• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchJade Biosciences
    Picture of Jade Biosciences logo

    JBIO — Jade Biosciences News Story

    $14.910.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    • Market Cap
      $948.24m
    • Enterprise Value
      $487.03m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • JBIO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    JBIO Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:46 AM

    Picture of Jade Biosciences logoJade Biosciences
    18/10/2021 14:46
    NASDAQ TRADE HALT  AVTE.O  VOLATILITY TRADING PAUSE AT 09:46 AM
    

    Recent news on Jade Biosciences

    See all news
    • Brief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026

      30/09/2026 12:02
    • U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage

      12/08/2026 09:07
    • Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary

      11/08/2026 13:00
    • Jade Biosciences Q2 net loss widens as costs rise

      10/08/2026 12:12
    • Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million

      10/08/2026 12:01

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.